The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Galiè et al., N Engl J Med 353(20):2148-2157 November 17, 2005.

Correction
PreviousPrevious
Volume 354:2400-2401 June 1, 2006 Number 22
NextNext

Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Galiè, N.
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension . The appendix listing principal investigators and locations of centers participating in the Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group was inadvertently omitted from the article. It appears below.

The members of the SUPER study group were as follows (in order of the number of patients enrolled at each center): A. Manes, Bologna, Italy; W. Seeger, Giessen, Germany; A. Fijalkowska, Warsaw, Poland; M.R. Kramer, Petach Tikva, Israel; A.J. Peacock, Glasgow, United Kingdom; O. Sitbon, Clamart, France; H. Al-hiti, Prague, Czech Republic; T. Pulido, Mexico City; I. Ben-Dov, Tel-Hashomer, Israel; A.E. Frost, . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.